Dr Reddy’s In-licenses Galena's Breast-Cancer Drug For India Development
This article was originally published in PharmAsia News
Executive Summary
Dr Reddy's Laboratories has formed a partnership involving development of Galena Bio's NeuVax (nelipepimut) preventative breast-cancer drug in India.
Dr Reddy's Laboratories has formed a partnership involving development of Galena Bio's NeuVax (nelipepimut) preventative breast-cancer drug in India. DRL Is to lead development of the drug as a treatment for preventing a recurrence of the cancer in remission as well as in gastric cancer. The companies did not disclose the financial arrangements, which involve development and sales milestone payments to the U.S.-based company, but did say royalties would be in the double digits. (Click here for more
)
"DRL In Deal With Galena Bio For Breast-Cancer Drug" - Indian Express (1/16/2014)